ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,980.87
-0.03%
US Tech 100
21,158.40
-0.02%
Dow Jones
42,171.66
-0.10%
Brent Oil
75.845
-2.18%
Bitcoin
104,578.53
-0.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Akebia Therapeutics Inc (AKBA) Quote

Akebia Therapeutics Inc

Akebia Therapeutics Inc (AKBA)

NASDAQ
3.56
0.06
(1.71%)
Closed June 20 4:00PM
15 min delayed - Upgrade to Realtime
3.55
-0.01
(-0.28%)
After Hours: 7:13PM
15 min delayed - Upgrade to Realtime

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.55
Bid
3.50
Ask
3.55
Volume
3,604,276
3.48 Day's Range 3.62
0.80 52 Week Range 4.0758
Market Cap
932.357M
Previous Close
3.50
Open
3.50
Last Trade
143
@
3.55
(formt)
Last Trade Time
Financial Volume
$ 12,852,301
VWAP
3.5658
Average Volume (3m)
4,930,309
Shares Outstanding
262,635,836
Dividend Yield
-
PE Ratio
-13.47
Earnings Per Share (EPS)
-0.26
Revenue
160.18M
Net Profit
-69.41M

About Akebia Therapeutics Inc

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment... Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.akebia.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Akebia Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AKBA. The last closing price for Akebia Therapeutics was $3.50. Over the last year, Akebia Therapeutics shares have traded in a share price range of $ 0.80 to $ 4.0758.

Akebia Therapeutics currently has 262,635,836 shares outstanding. The market capitalization of Akebia Therapeutics is $919.23 million. Akebia Therapeutics has a price to earnings ratio (PE ratio) of -13.47.

Ask ADVFN Intelligence (AI)

AKBA Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 13 2025
AKBA (1.71%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 11 2025
AKBA (1.71%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 11 2025
AKBA (1.71%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 11 2025
AKBA (1.71%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 05 2025
AKBA (1.71%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.43-10.80402010053.983.983.4650178013.57083803CS
40.724.56140350882.854.07582.760163115113.44703905CS
121.5981.12244897961.964.07581.5249303092.71205955CS
261.6788.8297872341.884.07581.5240641132.433274CS
522.51241.3461538461.044.07580.831684252.05798927CS
1563.2046927.7938621890.34544.07580.24129542961.33774101CS
260-8.61-70.805921052612.1613.780.24139164321.99944221CS

AKBA - Frequently Asked Questions (FAQ)

What is the current Akebia Therapeutics share price?
The current share price of Akebia Therapeutics is $ 3.55
How many Akebia Therapeutics shares are in issue?
Akebia Therapeutics has 262,635,836 shares in issue
What is the market cap of Akebia Therapeutics?
The market capitalisation of Akebia Therapeutics is USD 919.23M
What is the 1 year trading range for Akebia Therapeutics share price?
Akebia Therapeutics has traded in the range of $ 0.80 to $ 4.0758 during the past year
What is the PE ratio of Akebia Therapeutics?
The price to earnings ratio of Akebia Therapeutics is -13.47
What is the cash to sales ratio of Akebia Therapeutics?
The cash to sales ratio of Akebia Therapeutics is 5.84
What is the reporting currency for Akebia Therapeutics?
Akebia Therapeutics reports financial results in USD
What is the latest annual turnover for Akebia Therapeutics?
The latest annual turnover of Akebia Therapeutics is USD 160.18M
What is the latest annual profit for Akebia Therapeutics?
The latest annual profit of Akebia Therapeutics is USD -69.41M
What is the registered address of Akebia Therapeutics?
The registered address for Akebia Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Akebia Therapeutics website address?
The website address for Akebia Therapeutics is www.akebia.com
Which industry sector does Akebia Therapeutics operate in?
Akebia Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NWGLNature Wood Group Ltd
$ 5.615
(142.03%)
5.98M
KWEKWESST Micro Systems Inc
$ 11.2296
(94.96%)
37.36M
PTLEPTL Ltd
$ 0.3656
(84.74%)
404.15M
APVOAptevo Therapeutics Inc
$ 5.01
(77.66%)
124.47M
MRINMarin Software Incorporated
$ 1.435
(68.82%)
50.06M
CBIOCrescent Biopharma Inc
$ 14.60
(-71.45%)
97.59k
CEROCERo Therapeutics Holdings Inc
$ 11.5501
(-41.75%)
3.03M
BMEABiomea Fusion Inc
$ 1.90
(-34.48%)
11.66M
PSTVPlus Therapeutics Inc
$ 0.2025
(-34.38%)
23.9M
CONIGraniteShares ETF Trust 2X Short COIN Daily ETF
$ 3.7198
(-32.49%)
21.46M
HCTIHealthcare Triangle Inc
$ 0.0265
(19.91%)
455.2M
PTLEPTL Ltd
$ 0.3656
(84.74%)
404.15M
GNLNGreenlane Holdings Inc
$ 0.01035
(-0.48%)
260.94M
NVDANVIDIA Corporation
$ 145.48
(0.94%)
161.49M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.365
(3.56%)
141.16M

AKBA Discussion

View Posts
TrendTrade2016 TrendTrade2016 2 weeks ago
AKBA 3.99 LOL
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
AKBA WEEKLY BIO BEAST READY FOR 4.00
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
AKBA GAPPA...BIO BEAST AND NOBODY EVEN SEES IT
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
AKBA BIO BEAST WEEKLY CONTINUES
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
AKBA BIO BEAST HITTING NEW 52 WEEK HIGH
👍️ 1
TrendTrade2016 TrendTrade2016 3 weeks ago
AKBA LONG ON THIS BIO....3.00 CALLED HERE 3 MONTHS AGO...PRECISION CHARTING CAN SEE THGE FUTURE MANY WEEKS AND MONTHS IN ADVANCE ON THE WEEKLY
👍️0
glenn1919 glenn1919 3 weeks ago
AKBA..............................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
Firestorm22 Firestorm22 1 month ago
Not much happening here. AKBA makes a profit this quarter and the stock tanks back down. Too many shares outstanding (261,000,000).
👍️0
microchips microchips 2 months ago
At $2 this one is just warming up for the long haul to multiples higher. The key is the 2025 sales of Vafseo and then the expansion of use to non-dialysis patients into subsequent years.
👍️0
makinezmoney makinezmoney 3 months ago
$AKBA: Nuttssssssssssssssssssssss


Whats the deal here...... now $2.80

Someone wanna shed some light on this ???

GO $AKBA
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
ALKB FDA APPROVED BIO BEAST
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
AKBA READY FOR 3 BUCKS
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
AKBA WEEKLY BREAK OUT
👍️0
glenn1919 glenn1919 3 months ago
AKBA...............................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
AKBA BREAKING above 2.00 bio beast setting up
👍️0
microchips microchips 3 months ago
Wow. After that update somebody finally got this one figured out. It's going 5 to 10 dollars this year. Then, depending on the progress and outcome of the next trial start again August of 2025, we're talking 20 - 30 Dollars or more in 2026 and 27.
👍️0
Monksdream Monksdream 3 months ago
AKBA under $2
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
AKBA test that 2.50 from a year ago
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
AKBA breaking out
👍️0
glenn1919 glenn1919 5 months ago
AKBA....................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 months ago
akba........................https://stockcharts.com/h-sc/ui?s=akba&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 months ago
AKBA.............................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 months ago
AKBA.................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
AKBA.....................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
AKBA BIO BEAST INTO FDA
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
AKBA BEASTING LONG...FDA APPROVED DRUG COMES TO MARKET IN JAN
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
AKBA BUILDING 1.79 BREAK IS COMING
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
AKBA GAPPING AND READY FOR 1.79
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
AKBA BACK IN PLAY UNTIL JAN 2025...FDA COMING
👍️0
glenn1919 glenn1919 10 months ago
AKBA.....................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
AKBA................................https://stockcharts.com/h-sc/ui?s=ARKB&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 months ago
AKBA......................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 11 months ago
AKBA...........................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
Krspecialized Krspecialized 11 months ago
I believe the current news releases may have answered your question. GLTA
👍️0
Toofuzzy Toofuzzy 1 year ago
Why do you say we have a gold mine here ?

Toofuzzy
👍️0
Krspecialized Krspecialized 1 year ago
There's no doubt we have a gold mine here, and at some point it will be load up time. Figuring out when is the big question!
👍️0
eyeownu eyeownu 1 year ago
SCARY MOVIE
👍️0
eyeownu eyeownu 1 year ago
https://journey.ct.events/view/a825b116-e5ee-4e76-ad8d-2e9e9116aa21 tomorrows web cast
👍️0
eyeownu eyeownu 1 year ago
added 2k@ 1.11
👍️ 1
glenn1919 glenn1919 1 year ago
AKBA................................https://stockcharts.com/h-sc/ui?s=AKBA&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
AKBA under $2

👍️0
eyeownu eyeownu 1 year ago
ask is stacked! someone needs to slap it.
👍️0
eyeownu eyeownu 1 year ago
$AKBA RELOAD
👍️0
Firestorm22 Firestorm22 1 year ago
Starting to remind me of a “pump and dump” stock. Spikes up but always comes back down to where it started.
👍️0
Firestorm22 Firestorm22 1 year ago
Starting to remind me of a “pump and dump” stock. Spikes up but always comes back down to where it started.
👍️0
ErnieBilco ErnieBilco 1 year ago
I'm in at 33 cents so I'm not going anywhere, just gonna let it ride wherever it goes
👍️ 1
Firestorm22 Firestorm22 1 year ago
Thanks, I’m hanging onto it . With actual revenues of 40-60 mill the last 5 quarters, one would think this stock price should rise. I wouldn’t mind seeing them bought out.
👍️ 1
ErnieBilco ErnieBilco 1 year ago
Classic sell the news. Probable offering coming next week to dilute on the good news.
👍️0
Firestorm22 Firestorm22 1 year ago
Something just isnt right here. How do you get FDA approval for a drug and your stock price tank? Is there some bads news getting ready to come out on this company??
👍️0
Krspecialized Krspecialized 1 year ago
Long solid position here!
👍️0

Your Recent History

NASDAQ
AKBA
Akebia Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads